| Patient | Jean-Jacques Rousseau |
|---|---|
| Date of birth | 1712-06-28 |
| Identifiers | MRN HR-EN003-SYN-TD; SSN (made up) 000-03-2716 |
| Document date | 1767-07-14 |
| Author | Celestine Marchetti-Owusu, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Twelve-week review on aripiprazole; urethroplasty follow-up. [S]
Mr. Rousseau returns twelve weeks after starting aripiprazole 5 mg and about sixteen weeks after urethroplasty. He sleeps about six and a half hours most nights. He still believes some former friends speak against him, but he now spends under an hour a day on these thoughts rather than most of the day, opens his letters, and has written most mornings for a month. He has had fourteen CBT sessions and plans two more. He has had no restlessness, nausea, stiffness, or new urges, and has taken the tablet every morning. The four-week weight check was missed while he was away walking in the hills; his weight was taken at the sick visit for back strain five weeks ago, which has fully resolved. He passes urine freely and gets up once at night at most. He has had no thoughts of suicide or of harming anyone. [S]
| Element | Detail |
|---|---|
| Sleep | About six and a half hours |
| Beliefs | Present, held less firmly; under an hour a day of preoccupation |
| Medication | Aripiprazole 5 mg daily; no side effects; no missed doses |
| Psychotherapy | Fourteen CBT sessions |
| Voiding | Free stream; up once at night at most |
| Back strain | Resolved within three weeks |
| Safety | No thoughts of suicide or of harming anyone |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight up slightly; no fatigue |
| Genitourinary | Negative | Strong stream; no spraying, burning, or blood |
| Musculoskeletal | Negative | Back pain resolved |
| Neurological | Negative | No restlessness, tremor, stiffness, or abnormal movements |
| Endocrine | Negative | No thirst or excessive urination |
| Psychiatric | Positive | Persecutory beliefs persist with less conviction and distress; no hallucinations; no new urges; no thoughts of suicide or of harming anyone |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for pain, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 1767-03-24 | active | S |
| Aripiprazole 5 mg oral tablet, one tablet by mouth each morning | One tablet each morning | Oral route | 1767-04-21 | active | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth three times a day with food for up to seven days | One tablet three times a day with food | Oral route | 1767-06-09 to 1767-06-16 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1767-07-14 | Body height | 166 | cm | S |
| 1767-07-14 | Body weight | 64.4 | kg | S |
| 1767-07-14 | Body mass index (BMI) [Ratio] | 23.4 | kg/m2 | S |
| 1767-07-14 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1767-07-14 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1767-07-14 | Heart rate | 72 | /min | S |
| 1767-07-14 | Respiratory rate | 14 | /min | S |
| 1767-07-14 | Body temperature | 36.6 | Cel | S |
| 1767-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1767-07-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1767-07-14 | Symptom score [AUASI] | 5 | {score} | S | ||
| 1767-07-14 | If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that [IPSS] | 1 | {score} | S | ||
| 1767-07-14 | Maximum Urine flow by Uroflowmetry | 20.8 | mL/s | A maximum flow of 15 mL/s or more is normal for a voided volume above 150 mL | Normal | S |
| 1767-07-14 | US Urinary bladder Volume post void | 30 | mL | <=100 mL | Normal | S |
| 1767-07-14 | Creatinine [Mass/volume] in Serum or Plasma | 0.99 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1767-07-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1762)/1.73 sq M | 91 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1767-07-14 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1767-07-14 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 1767-07-14 | Cholesterol [Mass/volume] in Serum or Plasma | 201 | mg/dL | <=199 mg/dL | High | S |
| 1767-07-14 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 47 | mg/dL | >=40 mg/dL | Normal | S |
| 1767-07-14 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 126 | mg/dL | <=129 mg/dL | Normal | S |
| 1767-07-14 | Triglyceride [Mass/volume] in Serum or Plasma | 138 | mg/dL | <=149 mg/dL | Normal | S |
| 1767-07-14 | Waist Circumference at umbilicus by Tape measure | 93 | cm | Below 102 cm for men | Normal | S |
Vital signs recorded on 1767-07-14; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well and relaxed |
| Neurological | No tremor, rigidity, or involuntary movements; no akathisia |
| Genitourinary | Perineal scar healed; right inguinal hernia small and reducible, unchanged |
| Back | Full, painless movement |
| Mental status | Warm and courteous; mood "steadier than for years"; persecutory beliefs present but held with less conviction, and he can consider other explanations; no hallucinations; no suicidal or violent ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Fixed beliefs that former friends and colleagues are plotting to ruin him, with poor sleep, present for years and worse over the past year; cause not yet established; psychiatric and medical assessment under way | resolved | confirmed | R46.5 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis at the psychiatry consultation; his documented beliefs of 1766 are echoed. |
| Weak urinary stream, straining, incomplete emptying (post-void residual 180 mL), and painful urination since childhood, treated for years by self-dilation with urethral sounds; cause not yet established; urethral imaging and endoscopy booked | resolved | confirmed | R33.9 | S — Synthetic presenting concern at the index visit, superseded by the urethrogram and cystoscopy diagnosis; his documented lifelong retention and self-treatment with bougies are echoed. |
| Delusional disorder, persecutory type (DSM-5-TR), of about nine years' duration, with non-bizarre beliefs of a coordinated campaign against him; no hallucinations, disorganization, or mood episode; normal cognition; insomnia secondary to preoccupation; synthetic modern counterpart of his documented persecutory beliefs | active | confirmed | F22 | S — Synthetic modern diagnosis. His beliefs and conduct are documented (D); calling them a paranoid delusion is a retrospective interpretation (R), made difficult by the real persecution he suffered. |
| Bulbar urethral stricture, 1.5 cm, dense and ring-like (lumen about 8 French), idiopathic and probably congenital in origin, with decades of self-dilation; bladder trabeculation without hydronephrosis; kidney function normal; synthetic modern counterpart of his documented lifelong urinary retention | active | confirmed | N35.812 | S — Synthetic modern diagnosis. His lifelong retention is documented (D); its cause is disputed (R), and the autopsy found no urethral lesion (D), so this stricture is not presented as his historical diagnosis. |
| Right inguinal hernia, reducible and minimally symptomatic, likely aggravated by years of straining to pass urine | active | confirmed | K40.90 | S — Synthetic finding on examination; it echoes the documented rupture of 1758, whose site the source does not state. |
| Acute low back strain after splitting firewood, without sciatica, red flags, or urinary retention (bladder scan 20 mL); resolved within three weeks | resolved | confirmed | S39.012A | S — Synthetic common injury; the wood-splitting echoes a documented habit (CLM-0020), but no back injury is documented. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Suicide and violence risk review (C-SSRS Since Last Visit, PHQ-9 item 9, thoughts of harming others, plans to confront anyone, access to weapons) and the safety plan | Every visit | Completed today | No thoughts of suicide or of harming anyone; no plan to confront anyone; no weapons; PHQ-9 item 9 scored 0; safety plan reviewed |
| Survey | PHQ-9 for depressive symptoms | At least monthly | Completed today | 4, down from 8 at intake; monthly scores of 5 and 4 recorded at CBT sessions |
| Examination | Weight four weeks after starting aripiprazole | Weight at 4, 8, and 12 weeks | Deferred | Missed: the four-week weight was not taken because he was away and no visit was booked. The weight at seven weeks (64.0 kg, at the sick visit) and today's weight (64.4 kg, up 1.9 percent) show no clinically important gain, so no harm resulted. Corrective action: future early weight checks will be booked as nurse visits at the time a drug is started |
| Examination | Weight, BMI, waist, and blood pressure at twelve weeks | Weight at 12 weeks then quarterly; waist and blood pressure at 12 weeks then yearly | Completed today | 64.4 kg, BMI 23.4, waist 93 cm, 124/78 mmHg |
| Laboratory | Fasting glucose, hemoglobin A1c, and lipids at twelve weeks | Baseline, 12 weeks, then yearly | Completed today | Glucose 94 mg/dL, A1c 5.5 percent, total cholesterol 201, HDL 47, LDL 126, triglycerides 138 mg/dL |
| Examination | Akathisia check | Each visit on an antipsychotic | Completed today | None |
| Examination | AIMS | Baseline and every 6 months | Due | Next at six months on aripiprazole |
| Medication safety | Adherence and adverse-effect review | Every visit | Completed today | No missed doses; no nausea, restlessness, or impulse-control symptoms |
| Referral | Cognitive behavioral therapy for psychosis | About 16 sessions | Completed today | Fourteen sessions; two more planned with a relapse-prevention plan |
| Survey | IPSS and quality-of-life score | At each surveillance visit | Completed today | IPSS 5; quality of life 1 |
| Imaging | Uroflowmetry and post-void residual | About 3, 6, and 12 months after urethroplasty | Completed today | Maximum flow 20.8 mL/s; residual 30 mL |
| Imaging | Urethroscopy or urethrogram | Only with symptoms or a fall in flow | Not indicated | No symptoms and a normal flow |
| Laboratory | Creatinine and eGFR | Yearly after relief of obstruction, or with symptoms | Completed today | 0.99 mg/dL; eGFR 91 |
| Examination | Inguinal hernia check | At each review while under watchful waiting | Completed today | Unchanged |
Goal progress:
Guideline basis: The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition. Am J Psychiatry 2020;177(9):868-872 (2020); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (PHQ-9, suicide-risk review, and second-generation antipsychotic monitoring) (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Urethral Stricture Disease: AUA Guideline Amendment (2023). Wessells H, et al. J Urol 2023;210(1):64-71. PMID 37096574 (2023); International guidelines for groin hernia management. HerniaSurge Group. Hernia 2018;22(1):1-165 (2018)
Follow-up: Last two CBT sessions; urology flow test at six months; weight in three months; preventive visit in the autumn. Next scheduled visit 1767-09-22: adult preventive visit. [S]